These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Dissection of antiviral and immune regulatory functions of tumor necrosis factor receptors in a chronic lymphocytic choriomeningitis virus infection. Suresh M; Gao X; Fischer C; Miller NE; Tewari K J Virol; 2004 Apr; 78(8):3906-18. PubMed ID: 15047807 [TBL] [Abstract][Full Text] [Related]
63. Increased number of cytotoxic T cells within CD4+8- T cells in beta 2-microglobulin, major histocompatibility complex class I-deficient mice. Marusić-Galesić S; Udaka K; Walden P Eur J Immunol; 1993 Dec; 23(12):3115-9. PubMed ID: 8258325 [TBL] [Abstract][Full Text] [Related]
64. The expression of major histocompatibility complex (MHC) class I antigens in the brain differs markedly in acute and persistent infections with lymphocytic choriomeningitis virus (LCMV). Mucke L; Oldstone MB J Neuroimmunol; 1992 Feb; 36(2-3):193-8. PubMed ID: 1732281 [TBL] [Abstract][Full Text] [Related]
65. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules. Majlessi L; Bordenave G Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483 [TBL] [Abstract][Full Text] [Related]
66. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro. Ehl S; Klenerman P; Aichele P; Hengartner H; Zinkernagel RM Eur J Immunol; 1997 Dec; 27(12):3404-13. PubMed ID: 9464829 [TBL] [Abstract][Full Text] [Related]
67. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. Battegay M; Moskophidis D; Rahemtulla A; Hengartner H; Mak TW; Zinkernagel RM J Virol; 1994 Jul; 68(7):4700-4. PubMed ID: 7911534 [TBL] [Abstract][Full Text] [Related]
68. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. Kägi D; Odermatt B; Ohashi PS; Zinkernagel RM; Hengartner H J Exp Med; 1996 May; 183(5):2143-52. PubMed ID: 8642324 [TBL] [Abstract][Full Text] [Related]
69. Generation of cellular immunity to lymphocytic choriomeningitis virus is independent of CD1d1 expression. Spence PM; Sriram V; Van Kaer L; Hobbs JA; Brutkiewicz RR Immunology; 2001 Oct; 104(2):168-74. PubMed ID: 11683957 [TBL] [Abstract][Full Text] [Related]
70. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice. Yoshimura A; Shiku H; Nakayama E J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592 [TBL] [Abstract][Full Text] [Related]
71. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo. Kyburz D; Speiser DE; Aebischer T; Hengartner H; Zinkernagel RM J Immunol; 1993 Jun; 150(11):5051-8. PubMed ID: 7684417 [TBL] [Abstract][Full Text] [Related]
72. The lack of CD8 alpha cytoplasmic domain resulted in a dramatic decrease in efficiency in thymic maturation but only a moderate reduction in cytotoxic function of CD8+ T lymphocytes. Fung-Leung WP; Louie MC; Limmer A; Ohashi PS; Ngo K; Chen L; Kawai K; Lacy E; Loh DY; Mak TW Eur J Immunol; 1993 Nov; 23(11):2834-40. PubMed ID: 8223860 [TBL] [Abstract][Full Text] [Related]
73. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity. Sedlik C; Dadaglio G; Saron MF; Deriaud E; Rojas M; Casal SI; Leclerc C J Virol; 2000 Jul; 74(13):5769-75. PubMed ID: 10846055 [TBL] [Abstract][Full Text] [Related]
74. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. van der Most RG; Murali-Krishna K; Whitton JL; Oseroff C; Alexander J; Southwood S; Sidney J; Chesnut RW; Sette A; Ahmed R Virology; 1998 Jan; 240(1):158-67. PubMed ID: 9448700 [TBL] [Abstract][Full Text] [Related]
75. Agonistic anti-CD40 antibody profoundly suppresses the immune response to infection with lymphocytic choriomeningitis virus. Bartholdy C; Kauffmann SØ; Christensen JP; Thomsen AR J Immunol; 2007 Feb; 178(3):1662-70. PubMed ID: 17237416 [TBL] [Abstract][Full Text] [Related]
76. Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection. Lopez PA; Denny M; Hartmann AK; Alflen A; Probst HC; von Stebut E; Tenzer S; Schild H; Stassen M; Langguth P; Radsak MP J Dermatol Sci; 2017 Sep; 87(3):252-259. PubMed ID: 28655469 [TBL] [Abstract][Full Text] [Related]
78. Quantification of epitope-specific MHC class-II-restricted T cells following lymphocytic choriomeningitis virus infection. Kamperschroer C; Quinn DG Cell Immunol; 1999 May; 193(2):134-46. PubMed ID: 10222055 [TBL] [Abstract][Full Text] [Related]
79. Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice. Fang C; Miwa T; Shen H; Song WC J Immunol; 2007 Sep; 179(5):3178-86. PubMed ID: 17709533 [TBL] [Abstract][Full Text] [Related]
80. Effects of cyclosporin A on IL-2 production and lymphocyte proliferation during infection of mice with lymphocytic choriomeningitis virus. Kasaian MT; Biron CA J Immunol; 1990 Jan; 144(1):299-306. PubMed ID: 1967265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]